216 related articles for article (PubMed ID: 34367948)
21. Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bioinformatic investigation.
Qin H; Wen DY; Que Q; Zhou CY; Wang XD; Peng YT; He Y; Yang H; Liao BM
Oncol Lett; 2019 Dec; 18(6):6704-6724. PubMed ID: 31807180
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
[TBL] [Abstract][Full Text] [Related]
23. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
24. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
25. Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis.
Li C; Qin F; Hong H; Tang H; Jiang X; Yang S; Mei Z; Zhou D
PeerJ; 2019; 7():e7619. PubMed ID: 31534853
[TBL] [Abstract][Full Text] [Related]
26. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
Pan WY; Zeng JH; Wen DY; Wang JY; Wang PP; Chen G; Feng ZB
Oncol Lett; 2019 Feb; 17(2):1695-1713. PubMed ID: 30675229
[TBL] [Abstract][Full Text] [Related]
28. Identification of hub genes in peripheral blood mononuclear cells for the diagnosis of hepatocellular carcinoma using a weighted gene co-expression network analysis.
Ye Z; Zeng Z; Shen Y; Chen Z
Exp Ther Med; 2020 Aug; 20(2):890-900. PubMed ID: 32742331
[TBL] [Abstract][Full Text] [Related]
29. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
30. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Hu X; Bao M; Huang J; Zhou L; Zheng S
Front Oncol; 2020; 10():541479. PubMed ID: 33102213
[No Abstract] [Full Text] [Related]
32. Phosphatidylinositol glycan anchor biosynthesis, class C is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Zhao Q; Shen C; Wei J; Zhao C
Front Genet; 2022; 13():899407. PubMed ID: 36061167
[No Abstract] [Full Text] [Related]
33. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
34. Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Wen DY; Huang JC; Wang JY; Pan WY; Zeng JH; Pang YY; Yang H
Oncol Lett; 2018 Dec; 16(6):6918-6929. PubMed ID: 30546424
[TBL] [Abstract][Full Text] [Related]
35. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
Wang D; Liu J; Liu S; Li W
Front Genet; 2020; 11():342. PubMed ID: 32391055
[TBL] [Abstract][Full Text] [Related]
36. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
[TBL] [Abstract][Full Text] [Related]
37. Increased
Gao C; Shen J; Chen W; Yao L; Liang X; Zhu R; Chen Z
J Gastrointest Oncol; 2021 Aug; 12(4):1905-1926. PubMed ID: 34532138
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
Yang X; Pang YY; He RQ; Lin P; Cen JM; Yang H; Ma J; Chen G
FEBS Open Bio; 2018 Jan; 8(1):64-84. PubMed ID: 29321958
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]